Cytek Biosciences, Inc. (CTKB) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$4.69M | -118.5% |
| 2024 | $25.38M | +380.6% |
| 2023 | $5.28M | +143.2% |
| 2022 | -$12.23M | -364.2% |
| 2021 | $4.63M | -69.5% |
| 2020 | $15.16M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$4.69M | -118.5% |
| 2024 | $25.38M | +380.6% |
| 2023 | $5.28M | +143.2% |
| 2022 | -$12.23M | -364.2% |
| 2021 | $4.63M | -69.5% |
| 2020 | $15.16M | — |